[The effect of new synthetic prostanoids on the aggregation activity of human thrombocytes].
We found that a number of new synthetic prostanoids caused a prominent reduction of human platelet aggregation in the in vitro experiments. Moreover, two of this agents, IOS 3933 and IOS 4732, gives storage stability. Hemoxygenase activity, metabolic homeostasis of bilirubin in brain and transport function of serum albumin in animals receiving cobalt chloride.
Petrukhina
G N
GN
Makarova
V A
VA
FReĭmanis
Ia F
IaF
Lozha
E V
EV
D000244:Adenosine Diphosphate / Q000494:pharmacology; D001782:Blood Donors; D004305:Dose-Response Relationship, Drug; D004356:Drug Storage; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D011208:Powders; D011465:Prostaglandins, Synthetic / Q000494:pharmacology*; D012996:Solutions; D013997:Time Factors
D010975:Platelet Aggregation Inhibitors; D011208:Powders; D011465:Prostaglandins, Synthetic; D012996:Solutions; D000244:Adenosine Diphosphate
Vliianie novykh sinteticheskikh prostanoidov na agregatsionnuiu aktivnost' trombotsitov cheloveka.